Nephros Inc (STU:NPJP)
€ 2.98 -0.16 (-5.1%) Market Cap: 32.68 Mil Enterprise Value: 30.00 Mil PE Ratio: 57.17 PB Ratio: 3.48 GF Score: 50/100

Q2 2025 Nephros Inc Earnings Call Transcript

Aug 7, 2025 / 08:30 PM GMT
Release Date Price: €2.5 (+1.63%)

Key Points

Positve
  • Nephros Inc (NEPH) reported a 36% increase in net revenue for Q2 2025 compared to the same period in 2024, reaching $4.4 million.
  • The company achieved its third consecutive quarter of profitability, indicating strong operational execution.
  • Gross margins improved to 63% in Q2 2025, up from 59% in Q2 2024, driven by reduced shipping costs and inventory reserve adjustments.
  • Nephros Inc (NEPH) expanded its active customer sites to over 1,600 as of June 30, 2025, reflecting successful customer acquisition and retention strategies.
  • The company reported positive net income of $237,000 for the quarter, a significant improvement from a net loss of $289,000 in the same period last year.
Negative
  • Research and development expenses increased to $311,000 in Q2 2025 from $254,000 in Q2 2024, due to higher headcount.
  • Sales, general, and administrative expenses rose by 13% to $2.2 million in Q2 2025, driven by higher sales commissions, employee bonuses, and stock compensation expenses.
  • The company acknowledged that it does not have the salesforce needed in every location to support growth, indicating potential limitations in market expansion.
  • Despite the growth in active customer sites, there is a challenge in ensuring customers reorder filters at the recommended rate.
  • The company faces the ongoing challenge of expanding into underserved verticals and maintaining operational discipline while protecting profitability.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NEPH.OQ - Nephros Inc
Q2 2025 Nephros Inc Earnings Call
Aug 07, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and welcome to the Nephros Inc 2nd quarter 2025 financial results conference call. All participants will be in listen-only mode. If you need assistance, please signal a conference specialist by pressing the star key followed by 0. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then 1 on your telephone keypad. To withdraw your question, please press star then too. Please note this event is being recorded. I would now like to turn the conference over to Karen Smith investor relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
---------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot